Oncotarget

Vol 10, No 53

September 17, 2019

View Archive »

Order a Reprint

About The Cover

The cover for issue 53 of Oncotarget features Figure 5, "Preclinical models of Ewing’s sarcoma and osteosarcoma respond to DC101 alone and in combination with cytotoxic chemotherapy," by Lowery, et al.

Table of Contents

Editorial

Nicotinamide in the prevention of breast cancer recurrences?

Nicotinamide in the prevention of breast cancer recurrences?

https://doi.org/10.18632/oncotarget.27173

Giulia Dell’Omo,  and Paolo Ciana
5495-5496
PDF  |  How to cite  |  Order a Reprint

Research Papers

Consuming cholera toxin counteracts age-associated obesity

Consuming cholera toxin counteracts age-associated obesity

https://doi.org/10.18632/oncotarget.27137

Bernard J. Varian, Theofilos Poutahidis, Gordon Haner, Alex Hardas, Vanessa Lau,  and Susan E. Erdman
5497-5509
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin

Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin

https://doi.org/10.18632/oncotarget.27140

Devika Rao, Atrayee Basu Mallick, Titto Augustine, Cecilia Daroqui, Jeeshan Jiffry, Amartej Merla, Imran Chaudhary, Raviraja Seetharam, Arjun Sood, Srikanth Gajavelli, Santiago Aparo, Lakshmi Rajdev, Andreas Kaubisch, Jennifer Chuy, Abdissa Negassa, John M. Mariadason, Radhashree Maitra,  and Sanjay Goel
5510-5522
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

Anti-VEGFR2 therapy delays growth of preclinical pediatric tumor models and enhances anti-tumor activity of chemotherapy

Anti-VEGFR2 therapy delays growth of preclinical pediatric tumor models and enhances anti-tumor activity of chemotherapy

https://doi.org/10.18632/oncotarget.27148

Caitlin D. Lowery, Wayne Blosser, Michele Dowless, Matthew Renschler, Lisa V. Perez, Jennifer Stephens, Bronislaw Pytowski, Heather Wasserstrom, Louis F. Stancato,  and Beverly Falcon
5523-5533
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

The effects of focal adhesion kinase and platelet-derived growth factor receptor beta inhibition in a patient-derived xenograft model of primary and metastatic Wilms tumor

The effects of focal adhesion kinase and platelet-derived growth factor receptor beta inhibition in a patient-derived xenograft model of primary and metastatic Wilms tumor

https://doi.org/10.18632/oncotarget.27165

Jamie M. Aye, Laura L. Stafman, Adele P. Williams, Evan F. Garner, Jerry E. Stewart, Joshua C. Anderson, Smitha Mruthyunjayappa, Mary G. Waldrop, Caroline D. Goolsby, Hooper R. Markert, Colin Quinn, Raoud Marayati, Elizabeth Mroczek-Musulman, Christopher D. Willey, Karina J. Yoon, Kimberly F. Whelan,  and Elizabeth A. Beierle
5534-5548
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

New insights into the genomic landscape of meningiomas identified FGFR3 in a subset of patients with favorable prognoses

New insights into the genomic landscape of meningiomas identified FGFR3 in a subset of patients with favorable prognoses

https://doi.org/10.18632/oncotarget.27178

Aysha AlSahlawi, Rasha Aljelaify, Amna Magrashi, Mariam AlSaeed, Amal Almutairi, Fatimah Alqubaishi, Abdulellah Alturkistani, Abdullah AlObaid, Mohamed Abouelhoda, Latifa AlMubarak, Nada AlTassan,  and Malak Abedalthagafi
5549-5559
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Cathepsin L secretion by host and neoplastic cells potentiates invasion

Cathepsin L secretion by host and neoplastic cells potentiates invasion

https://doi.org/10.18632/oncotarget.27182

Samantha S. Dykes, Henrietta O. Fasanya,  and Dietmar W. Siemann
5560-5568
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Corrections

Correction: Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma

Correction: Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma

https://doi.org/10.18632/oncotarget.27205

Tiansuo Zhao, He Ren, Li Jia, Jing Chen, Wen Xin, Fan Yan, Jing Li, Xiuchao Wang, Song Gao, Dong Qian, Chongbiao Huang,  and Jihui Hao
5569-5570
Correction  |  PDF  |  How to cite

Correction: CNOT2 promotes degradation of p62/SQSTM1 as a negative regulator in ATG5 dependent autophagy

Correction: CNOT2 promotes degradation of p62/SQSTM1 as a negative regulator in ATG5 dependent autophagy

https://doi.org/10.18632/oncotarget.27211

Kwon Jeong, Hee Young Kwon, Myoung Seok Jeong, Eun Jung Sohn,  and Sung-Hoon Kim
5571-5571
Correction  |  PDF  |  How to cite

Retraction

Retraction: DNA-PKCS binding to p53 on the p21WAF1/CIP1 promoter blocks transcription resulting in cell death

Retraction: DNA-PKCS binding to p53 on the p21WAF1/CIP1 promoter blocks transcription resulting in cell death

https://doi.org/10.18632/oncotarget.27213

Richard Hill, Patricia A. Madureira, David. M. Waisman,  and Patrick W.K. Lee
5572-5572
Retraction  |  PDF  |  How to cite


Copyright © 2019 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC